Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for chronic cough and neurologically mediated conditions. Its lead candidate, Haduvio, is being evaluated for treating chronic pruritus and refractory cough. Chart
4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. is a biotechnology company pioneering genetic medicines. Using its proprietary vector evolution platform, the company develops targeted gene therapies for rare and common diseases, including ophthalmology and cardiology. Chart
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for cancer. Its pipeline targets genetic and molecular drivers of cancer, with a focus on hematologic and solid tumors. Chart
